Study Name:
CASCADE-LUNG (Cancer Screening Assay using DELFI): A Clinical Validation Study in Lung Cancer

Targeted Disease(s):
Lung Cancer

Purpose of Study:

We are recruiting approximately 15,000 individuals for a large-scale study to help determine the ability of our simple, blood-based screening technology to detect lung cancer accurately and reliably.

Study Dates:
August 1, 2022 - September 30, 2023

Study Location:
Nationwide

Lead Institution:
Thomas Jefferson University

Funding Source:
Delfi Diagnostics

ClinicalTrails.gov Identifier:
NCT05306288

Register for Trial
Asthma Educator Institute
, | Jul 11, 2022
Freedom From Smoking Clinic
Rochester, NY | Sep 16, 2022